文献速递衰弱、肌少症与跌倒老年慢病共病管理

衰弱前期与衰弱对COPD患者全因死亡率、急性加重及住院的关联:一项Meta分析

Association of Prefrailty and Frailty With All-Cause Mortality, Acute Exacerbation, and Hospitalization in Patients With Chronic Obstructive Pulmonary Disease: A Meta-Analysis.
PubMed 文献 · J Am Med Dir Assoc · 2023-05-05

衰弱显著预测COPD患者全因死亡率(校正HR 2.64,95%CI 1.74-4.02),衰弱前期与死亡率关联无显著差异(HR 1.48,95%CI 0.92-2.40)。衰弱显著预测所有急性加重(OR 2.20,95%CI 1.26-3.81),但对中重度急性加重无显著预测(OR 1.42,95%CI 0.94-2.17)。

要点

  • 衰弱显著预测COPD患者全因死亡率(校正HR 2.64,95%CI 1.74-4.02)。
  • 衰弱前期与全因死亡率关联无显著差异(HR 1.48,95%CI 0.92-2.40)。
  • 衰弱预测所有急性加重(OR 2.20),但不预测中重度急性加重(OR 1.42)。

核心结论

  • 衰弱显著预测COPD患者全因死亡率,即使校正常见混杂因素后仍显著。
  • 衰弱显著预测所有急性加重,但不预测中重度急性加重。
  • 全因住院的合并结果在逐一剔除敏感性分析中不可靠。

研究设计与样本

  • 衰弱患病率范围为6.0%至51%。

主要发现

  • 与非衰弱相比,衰弱前期全因死亡率校正HR为1.48(95%CI 0.92-2.40),衰弱为2.64(95%CI 1.74-4.02)。
  • 与非衰弱相比,衰弱前期全因住院校正OR为1.35(95%CI 1.05-1.74),衰弱为1.65(95%CI 1.05-2.61)。
  • 在稳定期COPD患者中,衰弱显著预测所有急性加重(OR 2.20,95%CI 1.26-3.81),但不预测中重度急性加重(OR 1.42,95%CI 0.94-2.17)。
  • 全因住院的合并结果在逐一剔除敏感性分析中不可靠。

关键数值与推荐

  • 衰弱前期全因死亡率校正HR 1.48(95%CI 0.92-2.40),衰弱校正HR 2.64(95%CI 1.74-4.02)。
  • 衰弱前期全因住院校正OR 1.35(95%CI 1.05-1.74),衰弱校正OR 1.65(95%CI 1.05-2.61)。
  • 衰弱预测所有急性加重OR 2.20(95%CI 1.26-3.81),中重度急性加重OR 1.42(95%CI 0.94-2.17)。

临床怎么用

  • 对COPD患者评估衰弱状态可能改善二级预防并允许早期干预。

局限性

  • 全因住院的合并结果在逐一剔除敏感性分析中不可靠。
  • 未来需要研究验证采用标准化衰弱定义对急性加重和全因住院的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the impact of prefrailty and frailty on all-cause mortality, acute exacerbation, and all-cause hospitalization in patients with chronic obstructive pulmonary disease (COPD). DESIGN: Meta-analysis. SETTING AND PARTICIPANTS: Two authors independently searched PubMed, Web of Science, and Embase databases until December 27, 2022,to identify studies that reported the predictive value of prefrailty and frailty in COPD patients. MEASUREMENTS: All-cause mortality, acute exacerbation, and all-cause hospitalization. RESULTS: Ten studies reporting on 11 articles enrolling 13,203 patients with COPD were included. The prevalence of frailty ranged from 6.0% to 51%. When compared with nonfrailty, the pooled adjusted hazard ratio (HR) of all-cause mortality was 1.48 (95% CI 0.92-2.40) for prefrailty and 2.64 (95% CI 1.74-4.02) for frailty, respectively. The pooled adjusted odds ratio (OR) of all-cause hospitalization was 1.35 (95% CI 1.05-1.74) for prefrailty and 1.65 (95% CI 1.05-2.61) for frailty. In addition, frailty significantly predicted all acute exacerbation (OR 2.20, 95% CI 1.26-3.81) but not moderate to severe acute exacerbation (OR 1.42, 95% CI 0.94-2.17) in patients with stable COPD. However, the pooled results of all-cause hospitalization were not reliable in leave-1-out sensitivity analyses. CONCLUSIONS AND IMPLICATIONS: Frailty significantly predicts all-cause mortality in patients with COPD, even after adjustment for common confounding factors. Assessment of frail status in COPD patients may improve secondary prevention and allow early intervention. However, future studies are warranted to validate the impact of frailty defined by a standardized definition of frailty on acute exacerbation and all-cause hospitalization.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Xu J, Xu W, Qiu Y, et al. Association of Prefrailty and Frailty With All-Cause Mortality, Acute Exacerbation, and Hospitalization in Patients With Chronic Obstructive Pulmonary Disease: A Meta-Analysis. J Am Med Dir Assoc. 2023. PMID: 37150209. doi:10.1016/j.jamda.2023.03.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。